What is the recommended dosing and administration of midazolam for an adult with refractory seizures, including IV and intranasal routes, repeat dosing, and monitoring?

Midazolam for Adult Refractory Seizures

For adults with refractory status epilepticus, administer IV midazolam as a loading dose of 0.15-0.20 mg/kg followed by continuous infusion starting at 1 mcg/kg/min (0.06 mg/kg/h), titrating upward by 1 mcg/kg/min every 15 minutes until seizures stop, with a maximum of 5 mcg/kg/min (0.3 mg/kg/h). 1

IV Administration for Refractory Status Epilepticus

Loading Dose

• 0.15-0.20 mg/kg IV administered over at least 2-3 minutes 1, 2
• Do NOT administer as rapid IV push—this increases risk of apnea 2

Continuous Infusion Protocol

• Initial rate: 1 mcg/kg/min (0.06 mg/kg/h) 1, 2
• Titration: Increase by 1 mcg/kg/min every 15 minutes until seizures cease 1
• Maximum rate: 5 mcg/kg/min (0.3 mg/kg/h) 1

Critical nuance: Recent evidence suggests higher doses (up to 0.4-1.0 mg/kg/h) may be more effective with acceptable safety profiles 3. A 2014 study demonstrated that high-dose protocols (median 0.4 mg/kg/h) reduced withdrawal seizures from 64% to 15% and decreased mortality compared to traditional lower-dose protocols 3. However, the pediatric guideline maximum remains the standard recommendation 1.

Alternative Routes When IV Access Unavailable

Intramuscular (IM):

• 0.2 mg/kg IM (maximum 6 mg per dose) 1
• May repeat every 10-15 minutes 1
• Onset within 15 minutes, peaking at 30-60 minutes 4
• Efficacy comparable to IV diazepam with faster onset when IV access is problematic 5

Intranasal (IN):

• Not recommended as first-line for adults with refractory seizures based on available evidence
• Systematic review shows 72.7% success rate for seizure termination but 61-75% recurrence rate 6
• Real-world data demonstrates intranasal route increases need for rescue therapy by 6.5% compared to IM administration 7
• If used: doses range 2.5-20 mg per administration, though optimal adult dosing remains unclear 6

Repeat Dosing Strategy

For IM administration when seizures persist:

• Repeat 0.2 mg/kg every 10-15 minutes as needed 1
• Maximum single dose: 6 mg 1

For continuous IV infusion:

• Do not give repeat boluses—instead titrate infusion rate upward 1, 2
• If breakthrough seizures occur on infusion, increase rate by 1 mcg/kg/min 1

Critical Monitoring Requirements

Respiratory Monitoring (Highest Priority)

• Continuous pulse oximetry mandatory 1, 2
• Prepare for respiratory support BEFORE administration 1, 2
• Apnea can occur up to 30 minutes after last dose 8
• Risk dramatically increased when combined with opioids or other CNS depressants 1, 2

Cardiovascular Monitoring

• Continuous blood pressure monitoring during infusion 2
• Hypotension more common with rapid administration and higher doses 3
• In hemodynamically compromised patients, titrate loading dose in small increments 2

Neurological Monitoring

• EEG monitoring strongly recommended to confirm seizure cessation 1
• Clinical cessation may not correlate with electrical seizure activity

Important Clinical Pitfalls

Dose Reduction Required:

• Age >60 years: Reduce dose by 20% or more 8, 2
• Hepatic/renal impairment: Clearance reduced 8
• Obesity: Clearance reduced 8
• Concurrent opioids or CNS depressants: Reduce dose by ~30% 8

Flumazenil Considerations:

• Available to reverse life-threatening respiratory depression 1, 2
• WARNING: Will also reverse anticonvulsant effects and may precipitate seizures 1
• Use only for life-threatening respiratory compromise, not routine oversedation 1

Administration Errors to Avoid:

• Rapid IV push causes increased apnea risk 2
• Inadequate time between dose titrations (must wait 2-3 minutes for peak effect) 2, 4
• Failure to prepare airway equipment before administration 1, 2
• Intra-arterial injection or extravasation—use caution 4

Context: Position in Treatment Algorithm

Midazolam for refractory status epilepticus is indicated when:

• Benzodiazepines (lorazepam preferred) have failed 1
• Second-line agents (phenytoin, levetiracetam, valproate) are being considered or have failed 9, 10

Note that lorazepam (0.05-0.10 mg/kg, max 4 mg, repeat every 10-15 min) remains first-line for initial IV treatment of status epilepticus 1. Midazolam is specifically positioned for refractory cases not controlled by standard therapies 1.